A healthier you.
At your own pace.

Semaglutide supports weight management alongside diet and activity in eligible patients. A prescriber assesses suitability.

It is injected under the skin weekly. Follow your prescribed dose and pen training; do not change doses yourself.

Mention all medicines, diabetes, eye disease, pancreatitis, delayed stomach emptying and planned anaesthesia.

Do not use during pregnancy or breastfeeding. Stop at least two months before a planned pregnancy, with your prescriber’s advice.

Nausea, vomiting, diarrhoea and constipation may occur. Keep hydrated. Severe persistent abdominal pain requires stopping treatment and urgent medical advice. Sudden vision loss needs urgent assessment. Breathing difficulty or facial swelling needs emergency help.

Within five days, use the missed dose; after five days, skip it and resume the usual day. Never double a dose. Ask your pharmacist if unsure.

Liraglutide supports weight management with diet and exercise in eligible patients. Your clinician reviews suitability and progress.

It is injected under the skin daily. The dose is increased gradually as prescribed. Rotate injection sites and follow pen training.

Tell your prescriber about all medicines, pregnancy plans, kidney or liver problems, thyroid disease, pancreatitis, severe digestive problems and planned anaesthesia.

Do not use during pregnancy or breastfeeding. Speak to your prescriber if you may be pregnant or are planning a baby.

Nausea, vomiting, diarrhoea, constipation and headache are very common. Severe persistent abdominal pain can signal pancreatitis: stop and seek urgent medical help. Severe upper-right abdominal pain also needs urgent advice. Breathing difficulty or throat swelling needs emergency help.

If remembered within 12 hours of the usual time, take it. Otherwise skip it and resume the next day. Do not double the dose.

Tirzepatide is prescribed for type 2 diabetes and adult weight management, with diet and activity, when clinically suitable.

Inject under the skin weekly, following your prescribed dose and pen instructions. Do not use medicine left after the pen’s four doses.

Mention all medicines, insulin, digestive problems, pancreatitis, diabetic eye disease and planned anaesthesia.

Do not use during pregnancy. For women with overweight or obesity using oral contraception, add a barrier method or switch to non-oral contraception for four weeks after starting and each dose increase. Discuss breastfeeding with your doctor.

Digestive side effects and dehydration can occur. Stop and seek urgent help for severe persistent abdominal pain. Breathing difficulty or rapid lip, tongue or throat swelling needs emergency help. Insulin or sulphonylureas can increase low-blood-sugar risk.

Within four days, take it; later, skip it. Never double a dose. Keep at least three days between doses.

Orlistat reduces absorption of dietary fat and is used with a calorie-controlled diet for obesity.

Follow your prescription. The leaflet describes one 120 mg capsule with each main meal, just before, during or up to one hour afterwards. Omit it if the meal is missed or contains no fat.

Mention all medicines, especially anticoagulants, ciclosporin, thyroid, epilepsy and HIV treatments. Do not use with chronic malabsorption, cholestasis or while breastfeeding. Pregnancy use is not recommended.

Oily stools, urgency and wind are common. High-fat meals increase digestive effects. Seek medical advice for rectal bleeding. Stop and contact a doctor for jaundice or dark urine with abdominal pain. Severe breathing difficulty needs emergency help.

Take it only if within one hour of the meal; otherwise resume at the usual time. Never double a dose.

Severe diarrhoea may affect oral contraception. Use an additional contraceptive method and ask your pharmacist for advice.